BMSSC
CNMD icon

B. Metzler seel. Sohn & Co’s CONMED CNMD Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,898
Closed -$524K – 723
2025
Q4 		$524K Sell
12,898
-6,510
-34% -$283K ﹤0.01% 639
2025
Q3 		$913K Buy
+19,408
New +$1.01M 0.01% 557

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

B. Metzler seel. Sohn & Co's CNMD Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co sold out of CONMED (CNMD) in Q1 2026, closing a stake of 12,898 shares — an estimated $524K sold.

B. Metzler seel. Sohn & Co first reported a position in CNMD in Q3 2025 and held it in 2 quarters. The position peaked at $913K in Q3 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • B. Metzler seel. Sohn & Co reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 12,898 CONMED shares in Q1 2026, an estimated $524K.
  • B. Metzler seel. Sohn & Co first reported a position in CONMED in Q3 2025 and held it in 2 quarters.
  • B. Metzler seel. Sohn & Co's CONMED position peaked at $913K in Q3 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.